Vertex Pharmaceuticals: R&D Portfolio Management (A) Case Solution
Vertex Pharmaceuticals, Inc., a drug discovery company that recently decided to pursue a vertically integrated business model, picked to build up its clinical development and commercial abilities and infrastructure.
For the very first time in its history, Vertex will pick two drug candidates from its internal research portfolio of four projects to develop by itself, without the aid of strategic partners. President Vicki Sato and CEO Joshua Boger are grappling with which two projects to choose. Furthermore, this note focuses on the way to handle the procedure for portfolio selection and how to select projects.
PUBLICATION DATE: June 10, 2004
This is just an excerpt. This case is about TECHNOLOGY & OPERATIONS
Related Case Solutions & Analyses:
Aviation Spare Parts Supply Chain Management Optimisation at Cathay Pacific Airways Limited
Bunge: Food Fuel and World Markets
Walt Disneys Dennis Hightower: Weaving Together the European Operations
Star Distributors Inc. (B)
Nike in Transition (A): The Ascendancy of Bob Woodell
adidas Group: IT Multi-Sourcing at adidas
Challenges of the 21st Century: Natural Disasters
Successfully Navigating the Turbulent Skies of a Large-Scale ERP Implementation
Steel-Making at POSCO
BAE Automated Systems (B): Implementing the Denver International Airport Baggage-Handling System
